NYSE: EPCEdgewell Personal Care
Edgewell Personal Care Q4 2026 Results: Net Income $10.9 Million on Revenue of $484 Million
- US stocks
- Earnings
- Consumer Staples
Edgewell Personal Care (NYSE: EPC) reported fiscal 2026 fourth quarter results in which net sales were $484.1 million, up 3.0% from a year earlier, and net income (GAAP) was $10.9 million, against a net loss of $30.6 million in the prior-year quarter. Diluted EPS (GAAP) was $0.23, and the company's adjusted EPS, a company-defined measure that excludes restructuring and other listed items, was $0.78; it said on 12 Nov 2026 that the results were for the quarter ended 30 Sep 2026.
Key highlights
- Revenue: $484.1 million, up 3.0% YoY
- Net income: $10.9 million, against a loss of $30.6 million a year earlier (GAAP)
- Diluted EPS (GAAP): $0.23 per share, against $-0.66 a year earlier
- Adjusted EPS (company-defined): $0.78 per share, against $0.52 a year earlier
Summary
| Particulars | Q4 2026 | Q4 2025 | YoY |
|---|---|---|---|
| Revenue | 484.1 | 469.9 | +3.0% |
| 16.9 | 6.9 | +144.9% | |
| Operating margin | 3.49% | 1.47% | +2.02 pp |
| 10.9 | -30.6 | n/a | |
| Net income margin | 2.25% | -6.51% | +8.76 pp |
| Diluted EPS ($) | 0.23 | -0.66 | n/a |
Figures are in $ million except EPS; YoY compares with Q4 2025. Q4 2026 is the three months to 30 Sep 2026, from the company's release. Earlier quarters are the release's own comparatives, not cross-checked against SEC XBRL data. GAAP; net income attributable to the company; diluted EPS. Changes and margins computed by Blacklitt.
Net sales rose 3.0% to $484.1 million, and the company reports organic net sales growth of 3.1% excluding currency movements. GAAP operating income rose to $16.9 million from $6.9 million, a margin of 3.5% of net sales against 1.5% a year earlier, the company's own margin measure in the release is adjusted operating margin of 10.6%.
The table compares with the fourth quarter of fiscal 2025 as printed in the release. The year-ago figures were not cross-checked against the company's SEC XBRL data. The company reported a GAAP net loss for fiscal 2026 as a whole, which is shown in the release's full-year columns rather than in this table.
Adjusted figures exclude restructuring costs
Adjusted EPS of $0.78 is a company-defined measure. Adjusted net earnings from continuing operations were $36.8 million, against GAAP net earnings from continuing operations of $10.7 million. The adjustments include pre-tax restructuring and related costs of $29.9 million in the quarter, along with smaller items such as legal matters and Sun Care reformulation costs.
The company attributes the rise in adjusted gross margin to 45.7% partly to productivity savings, favourable volume absorption, favourable currency and the lapping of transitory costs in the prior year.
Segments and cash position
Wet Shave net sales were $325.8 million in the quarter, and segment profit was $58.7 million. Sun and Skin Care net sales were $158.3 million, and segment profit was $19.7 million.
The company ended the quarter with $375.6 million in cash and cash equivalents and access to an additional $418.8 million under its U.S. revolving credit facility.
Outlook for fiscal 2027
The company expects GAAP EPS of $0.90 to $1.20 and adjusted EPS of $1.85 to $2.15 for fiscal 2027. It expects reported net sales to rise about 0.4% to 2.4% and organic net sales about 1.0% to 3.0%, with adjusted EBITDA of $250 million to $270 million.
The company expects pre-tax charges of approximately $55 million in fiscal 2027 for restructuring and repositioning actions. Previous outlook ranges are not given in the release.
Inference
For each share, the company declared a quarterly cash dividend of $0.15 per share on 12 Nov 2026 for the fourth fiscal quarter, payable on 7 Jan 2027 to shareholders of record at the close of business on 3 Dec 2026. Dividends paid in the quarter totaled $6.9 million. Diluted weighted-average shares were 47.2 million in the quarter, against 46.5 million a year earlier, and fiscal 2026 share repurchases were $15.8 million. As of 30 Sep 2026 about $85 million remained under the Board's 2025 authorization.
The release does not state the amount of share repurchases made in the fourth quarter alone, or whether the remaining authorization will be used in fiscal 2027.
Filed with the US SEC on . Reference: Original filing (SEC)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.

